Omentin-1 vs Calcitonin
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Calcitonin (Salmon Calcitonin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Omentin-1 | Calcitonin |
|---|---|---|
| Category | Diabetes & Metabolic | Pain Management |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Salmon Calcitonin |
| Molecular Weight | ~35 kDa | 3431.9 Da |
| Half-Life | hours | about 10-15 minutes |
| Amino Acids | 313 | 32 |
| Typical Dose | No approved human dose; research use only | 100 IU/day SC or 200 IU/day intranasal |
| Route | IV|SC | Intranasal/Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 82 | 350 |
| Research Status | Pre-clinical | Approved |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
Calcitonin Benefits
- ✓bone pain relief
- ✓short-term analgesic effect
- ✓may reduce opioid requirement
- ✓useful in osteoporotic fracture pain
Omentin-1 Dosing
not established|not established
Calcitonin Dosing
100 IU subcutaneous daily|200 IU intranasal daily|short-term use in acute pain settings
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Calcitonin Side Effects
- ⚠nausea
- ⚠flushing
- ⚠rhinitis
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Calcitonin
Calcitonin has been evaluated in randomized trials and reviews for pain associated with vertebral compression fractures and other bone-related conditions. The signal is strongest for short-term analgesia rather than long-term chronic pain control.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.